Suppr超能文献

缺乏血管活性肠肽诱导型VPAC(2)受体的小鼠迟发型超敏反应增强,速发型超敏反应减弱。

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

作者信息

Goetzl E J, Voice J K, Shen S, Dorsam G, Kong Y, West K M, Morrison C F, Harmar A J

机构信息

Department of Medicine and Immunology, University of California Medical Center, San Francisco, CA 94143-071, USA.

出版信息

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13854-9. doi: 10.1073/pnas.241503798. Epub 2001 Nov 6.

Abstract

Vasoactive intestinal peptide (VIP) and its G protein-coupled receptors, VPAC(1)R and VPAC(2)R, are prominent in the immune system and regulate many aspects of T cell-dependent immunity. In mouse T cells, VPAC(1)R is expressed constitutively, whereas VPAC(2)R is induced by immune stimuli. VPAC(2)R-null (VPAC(2)R(-/-)) mice on a C57BL/6 background are shown here to have normal basic immune characteristics, including serum Ig concentrations, blood levels of all leukocytes, and spleen number of total T cells (CD3(+)) and T cells bearing CD4, CD8, and CD28. Hapten-evoked cutaneous delayed-type hypersensitivity (DTH) was significantly enhanced in VPAC(2)R-null mice compared with age- and sex-matched wild-type mice. In contrast, generation of IgE anti-hapten antibodies and active cutaneous anaphylaxis were > or =70% lower in VPAC(2)R-null mice than in wild-type controls. Cytokine production by splenic CD4(+) T cells, stimulated with adherent anti-CD3 plus anti-CD28 antibodies, revealed higher levels of IL-2 (mean = 3-fold) and IFN-gamma (mean = 3-fold), and lower levels of IL-4 (mean = one-fifth) in VPAC(2)R-null mice than wild-type controls. Loss of VIP-VPAC(2)R maintenance of the normal ratio of Th2/Th1 cytokines thus leads to a state of enhanced DTH and depressed immediate-type hypersensitivity, which may alter both host defense and susceptibility to immune-mediated diseases.

摘要

血管活性肠肽(VIP)及其G蛋白偶联受体VPAC(1)R和VPAC(2)R在免疫系统中很突出,并调节T细胞依赖性免疫的许多方面。在小鼠T细胞中,VPAC(1)R组成性表达,而VPAC(2)R由免疫刺激诱导。本文显示,C57BL/6背景的VPAC(2)R基因敲除(VPAC(2)R(-/-))小鼠具有正常的基本免疫特征,包括血清Ig浓度、所有白细胞的血液水平以及脾脏中总T细胞(CD3(+))以及携带CD4、CD8和CD28的T细胞数量。与年龄和性别匹配的野生型小鼠相比,VPAC(2)R基因敲除小鼠中半抗原诱发的皮肤迟发型超敏反应(DTH)显著增强。相反,VPAC(2)R基因敲除小鼠中IgE抗半抗原抗体的产生和主动皮肤过敏反应比野生型对照低≥70%。用贴壁抗CD3加抗CD28抗体刺激脾CD4(+) T细胞产生细胞因子,结果显示VPAC(2)R基因敲除小鼠中IL-2(平均为3倍)和IFN-γ(平均为3倍)水平较高,而IL-4水平(平均为五分之一)低于野生型对照。因此,VIP-VPAC(2)R维持Th2/Th1细胞因子正常比例的功能丧失导致DTH增强和速发型超敏反应受抑的状态,这可能会改变宿主防御以及对免疫介导疾病的易感性。

相似文献

5
Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide.
Regul Pept. 2002 Nov 15;109(1-3):199-208. doi: 10.1016/s0167-0115(02)00182-9.
6
Distribution of the VPAC2 receptor in peripheral tissues of the mouse.
Endocrinology. 2004 Mar;145(3):1203-10. doi: 10.1210/en.2003-1058. Epub 2003 Nov 14.
7
The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice.
Peptides. 2011 Jan;32(1):131-7. doi: 10.1016/j.peptides.2010.09.022. Epub 2010 Oct 13.
8
Excitatory actions of vasoactive intestinal peptide on mouse thalamocortical neurons are mediated by VPAC2 receptors.
J Neurophysiol. 2006 Aug;96(2):858-71. doi: 10.1152/jn.01115.2005. Epub 2006 Apr 26.
9
VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
J Pharmacol Exp Ther. 2005 Aug;314(2):745-52. doi: 10.1124/jpet.105.086405. Epub 2005 May 4.
10
Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses.
Clin Exp Immunol. 2007 Apr;148(1):178-87. doi: 10.1111/j.1365-2249.2007.03322.x.

引用本文的文献

1
Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation.
Cell Biochem Biophys. 2025 Jun;83(2):1963-1972. doi: 10.1007/s12013-024-01606-0. Epub 2024 Nov 17.
2
Sensory neurons: An integrated component of innate immunity.
Immunity. 2024 Apr 9;57(4):815-831. doi: 10.1016/j.immuni.2024.03.008.
4
Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia () against Infection.
Int J Mol Sci. 2022 Nov 28;23(23):14895. doi: 10.3390/ijms232314895.
5
Immunomodulatory Role of Neuropeptides in the Cornea.
Biomedicines. 2022 Aug 16;10(8):1985. doi: 10.3390/biomedicines10081985.
7
Regulatory Peptides in Asthma.
Int J Mol Sci. 2021 Dec 20;22(24):13656. doi: 10.3390/ijms222413656.
9
Neuro-Immunity Controls Obesity-Induced Pain.
Front Hum Neurosci. 2020 Jun 9;14:181. doi: 10.3389/fnhum.2020.00181. eCollection 2020.
10
The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity.
Nat Immunol. 2020 Feb;21(2):168-177. doi: 10.1038/s41590-019-0567-y. Epub 2019 Dec 23.

本文引用的文献

2
Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?
J Immunol. 2001 Mar 1;166(5):2907-12. doi: 10.4049/jimmunol.166.5.2907.
3
Vasoactive intestinal peptide mediation of development and functions of T lymphocytes.
Ann N Y Acad Sci. 2000;921:79-91. doi: 10.1111/j.1749-6632.2000.tb06953.x.
7
Vasoactive intestinal peptide in thymus: synthesis, receptors and biological actions.
Neuroimmunomodulation. 1999 Jan-Apr;6(1-2):97-107. doi: 10.1159/000026369.
10
Development of high affinity selective VIP1 receptor agonists.
Peptides. 1997;18(10):1539-45. doi: 10.1016/s0196-9781(97)00228-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验